Zhejiang Orient Gene Biotech Co., Ltd Stock
Equities
688298
CNE100003RM8
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.93 CNY | -2.00% |
|
-8.71% | -24.69% |
| Sep. 12 | Zhejiang Orient Gene Biotech to Set Up Philippine Subsidiary for $1.2 Million | MT |
| Sep. 03 | Zhejiang Orient Gene Biotech's Unit Gets Certificate to Conduct Research in US | MT |
| Capitalization | 5.43B 770M | P/E ratio 2022 |
6.26x | P/E ratio 2023 | -18.2x |
|---|---|---|---|---|---|
| Enterprise value | 820M 116M | EV / Sales 2022 |
0.6x | EV / Sales 2023 | 3.17x |
| Free-Float |
51.44% | Yield 2022 |
2.59% | Yield 2023 | - |
More valuation ratios
* Estimated data
More news
| 1 day | -2.00% | ||
| 1 week | -8.71% | ||
| Current month | -7.84% | ||
| 1 month | -8.40% | ||
| 3 months | -2.95% | ||
| 6 months | -13.88% | ||
| Current year | -24.69% |
1 week
26.66
28.61
1 month
26.4629.67
Current year
24.4037.38
1 year
24.4045.44
3 years
24.40245.01
5 years
24.40245.01
10 years
24.40245.01
| Director | Title | Age | Since |
|---|---|---|---|
Jian Qiu Fang
CEO | Chief Executive Officer | 41 | 10-05-31 |
Jin Hong Yu
DFI | Director of Finance/CFO | 52 | 13-05-31 |
Ye Ping Zhang
SEC | Corporate Secretary | 44 | 20-03-22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiao Liang Fang
CHM | Chairman | 66 | 05-11-30 |
Jian Qiu Fang
CEO | Chief Executive Officer | 41 | 10-05-31 |
Xiao Ping Fang
BRD | Director/Board Member | 60 | 09-11-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 12 M€ | -16.71% | - | |
| 0.03% | 12 M€ | +8.31% | ||
| 0.00% | 99 M€ | +7.74% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -8.71% | -30.74% | -72.25% | 784M | ||
| -1.66% | -3.36% | +15.00% | -4.96% | 14.22B | ||
| -0.03% | -0.70% | +6.43% | +48.84% | 7.62B | ||
| +1.35% | +3.90% | +77.00% | +324.91% | 7.54B | ||
| -1.20% | -1.01% | +13.98% | -48.58% | 6.19B | ||
| +0.08% | -2.02% | +64.28% | -51.87% | 3.23B | ||
| -0.08% | 0.00% | -17.07% | -27.50% | 3.16B | ||
| -3.47% | +1.03% | -50.26% | -86.03% | 2.83B | ||
| -0.95% | -3.26% | +8.28% | +462.38% | 2.62B | ||
| -2.44% | +0.33% | +62.82% | -16.78% | 2.57B | ||
| Average | -1.08% | -0.01% | +14.97% | +52.82% | 5.08B | |
| Weighted average by Cap. | -0.84% | +0.37% | +21.67% | +60.35% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 8.77B 1.24B | 820M 116M |
| Net income | 2.07B 293M | -398M -56.39M |
| Net Debt | -7.68B -1.09B | -4.61B -654M |
More financial data
* Estimated data
Employees
2,231
Calendar
2024-10-28
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-19 | 26.93 ¥ | -2.00% | 928,333 |
| 24-09-19 | 27.48 ¥ | +1.10% | 1,325,204 |
| 24-09-18 | 27.18 ¥ | -4.70% | 1,368,325 |
| 24-09-13 | 28.52 ¥ | -3.32% | 1,145,365 |
| 24-09-12 | 29.50 ¥ | +1.13% | 1,397,888 |
End-of-day quote Shanghai S.E., September 19, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 688298 Stock
